Shanghai Pharma braves weak market with $2.2 billion IPO
Shanghai Pharma's IPO beats the odds to find good demand in difficult market conditions.
May 03, 2011
- News
-
Investment Lifecycle
Deals & Trends
Rainmakers
Regions
- Research
-
- Awards
-
- Events
- Photo Gallery
